23 Aug 2022 --- A Seraphina Therapeutics study has found the “second-ever” discovered full-acting endocannabinoid pentadecanoylcarnitine, referred to as PDC. The US Navy Marine Mammal Program, Naval Warfare Information Center Pacific funded study reveals that the second endogenous cannabinoid to be discovered relies on the fatty acid C15:0.
